La vendita allo scoperto per Urban-gro dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Urban-gro. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Urban-gro (NASDAQ:UGRO) Azioni, Report sulle vendite allo scoperto

Urban-gro

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Urban-gro Inc

Earnings

News

Comerica Q3 2024 Adj. EPS $1.37 Beats $1.16 Estimate, Sales $811.000M Miss $811.617M Estimate

<p>HC Wainwright &amp; Co.  analyst Joseph Pantginis   reiterates Adlai Nortye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANL#NASDAQ">ANL</a>) with a Buy and maintains $9 price target.</p>


Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Adlai Nortye, Maintains $9 Price Target

<p>HC Wainwright &amp; Co.  analyst Edward White   maintains Aura Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) with a Buy and raises the price target from $21 to $22.</p>


AURA

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22

<p>The collaboration supports the licensing of part of Curiosity Stream&#39;s content portfolio in China, Hong Kong, and Macau, bringing 56 unique titles, amounting to 148 hours of premium factual content, to audiences across these territories through various platforms. The deal encompasses a diverse range of programming, from short-form documentary series to premium long-form content.</p>


CURI

Curiosity Inks Strategic Distribution Partnership With Off The Fence; Deal Broadens Company's Footprint Across China, Hong Kong, And Macau

Guidance

CVS's Q3 Results Won't Meet Wall Street's Expectations; Plans To Back Away From Current 2024 Guidance

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates DRDGold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>) with a Buy and maintains $13.25 price target.</p>


HC Wainwright & Co. Reiterates Buy on DRDGold, Maintains $13.25 Price Target

Management

CVS Naming Caremark President David Joyner As Its New CEO

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $1.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $1.5 Price Target

Biotech

Large Cap

Health Care

General

The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12 Years Or Older With Hemophilia A Or B With Inhibitors.

<p>HC Wainwright &amp; Co.  analyst Heiko Ihle   reiterates First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and maintains $8.5 price target.</p>


HC Wainwright & Co. Reiterates Buy on First Majestic Silver, Maintains $8.5 Price Target

<p>The combined companies for the trailing twelve months have generated $235 million in revenue, increasing approximately&nbsp;25%&nbsp;quarter-over-quarter.</p>


BTTR

Better Choice Expects Combined 2025 Pro Forma Basis Revenue And EBITDA To Be Approximately +$270M, And +$10M, Respectively

Better Choice Says Continues To Make Progress Towards Closing Of Its Acquisition Of SRx Health Solutions; Expects Transaction To Close In Late Q4 Of This Year Or Early Q1 Of 2025

<p>Needham  analyst Ami Fadia   reiterates Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) with a Buy and maintains $23 price target.</p>


NMRA

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

<p>Based on sales trends and order intake in recent years, it expects further market share gains with domestic Chinese OEMs in the coming years.</p>
<p>With the seasonally strong fourth quarter remaining of the year, it reaffirms&nbsp;guidance of around 9.5-10.0% adjusted operating margin for 2024, but to be at the low end of this range.</p>
<p>&nbsp;</p>


Autoliv Now Expects Full Year 2024 Organic Sales Growth To Be 1% Instead Of Previously Expected 2% Due To Unfavorable Market Mix Development

<p>Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.53 by 7.55 percent. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year.  The company reported quarterly sales of $1.87 billion which beat the analyst consensus estimate of $1.80 billion by 3.78 percent.  This is a 0.54 percent increase over sales of $1.86 billion the same period last year.</p>


Earnings Beats

Regions Finl Q3 Adj $0.57 Beats $0.53 Estimate, Sales $1.87B Beat $1.80B Estimate

<p>HC Wainwright &amp; Co.  analyst Patrick Trucchio   reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $400 price target.</p>


ALNY

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

<p>Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) reported quarterly earnings of $1.84 per share which missed the analyst consensus estimate of $1.95 by 5.64 percent.  The company reported quarterly sales of $2.56 billion which beat the analyst consensus estimate of $2.53 billion by 0.89 percent.  This is a 1.58 percent decrease over sales of $2.60 billion the same period last year.</p>


Earnings Misses

Autoliv Q3 2024 Adj EPS $1.84 Misses $1.95 Estimate, Sales $2.56B Beat $2.53B Estimate

<p>HC Wainwright &amp; Co.  analyst Amit Dayal   reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.</p>


GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

<p>Needham  analyst Ami Fadia   reiterates Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and maintains $22 price target.</p>


Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

<p>Needham  analyst Mayank Tandon   maintains WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) with a Buy and lowers the price target from $70 to $60.</p>


Needham Maintains Buy on WNS (Hldgs), Lowers Price Target to $60

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Vertical farming is a hot topic with significant productivity-based advantages. In fact, the industry is forecasted to grow by <a href="https://straitsresearch.com/report/vertical-farming-market#:~:text=Market%20Overview,period%20(2023%E2%80%932031).">24.1% annually until 2031</a>, illustrating its potential. As a result, investors are looking into vertical farming stocks for massive returns. </p>



<p>Given the above, I embarked on a journey to find three undervalued vertical farming stocks. I was aware that value and growth traps are prominent due to the industry&rsquo;s immature state. As such, I applied a robust screening methodology, which looked at fundamental sustainability, valuation metrics, and structural growth. Moreover, I applied technical analysis where necessary to identify key pricing points.</p>



<p>Vertical farming stocks are risky as the industry has yet to consolidate, meaning related stocks aren&rsquo;t suitable for all investors. However, if your risk tolerance is high, then here are three vertical farming stocks worth considering.</p>



<h2>Urban-Gro (UGRO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/ugro-stock-1600-300x169.jpg" alt="LED lighting used to grow lettuce inside a warehouse without the need for sunlight"><div>Source: Martin Bergsma / Shutterstock.com</div></div><p><strong>Urban-Gro</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ugro-stock-quote/"><strong>UGRO</strong></a></span>) fulfills a critical role in the vertical farming industry: facility development. The company designs, develops, and manages value-added infrastructure tailored to numerous end markets.</p>



<p>Fundamentally, I enjoy Urban-Gro&rsquo;s nimble approach and early-to-market stature. However, I also find some of its other aspects commendable. For example, Urban-Gro recorded a hefty project backlog of <a href="https://feeds.issuerdirect.com/news-release.html?newsid=5989999038507398">$99 million in March</a>. Additionally, the company recently reported its first-quarter earnings, revealing $15.5 million in revenue, a 4% year-over-year increase. </p>



<p>The abovementioned variables play into a broader growth story, which is encouraging, as UGRO stock&rsquo;s price-to-sales ratio of <a href="https://finance.yahoo.com/quote/UGRO/key-statistics/">0.25x</a> suggests it is grossly undervalued. Moreover, UGRO stock&rsquo;s technical variables are aligned as it recently surpassed its ten- and 50-day moving averages, indicating a momentum trend has been shaped.</p>



<p>UGRO stock might be volatile for the foreseeable future, as Urban-Gro is an early-stage enterprise. Nevertheless, asymmetrical returns are possible if Urban-Gro&rsquo;s fundamental variables build on their recent progress.</p>



<h2>Village Farms International (VFF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/vff-stock-1600-300x169.jpg" alt="Hydroponics,Organic fresh harvested vegetables"><div>Source: bluedog studio / Shutterstock.com</div></div><p><strong>Village Farms International</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/vff-stock-quote/"><strong>VFF</strong></a></span>) is a horizontally integrated company that supplies numerous greenhouse goods in the U.S. and Canada. In addition to supplying fresh produce, Village Farms participates in the North American cannabis industry, providing an additional growth multiplier. Moreover, the company has operated for <a href="https://villagefarms.com/about/leadership/#:~:text=In%201989%2C%20he%20founded%20Village,chief%20visionary%20for%20the%20Company.">over thirty years</a>, translating into substantial human capital synergies across its verticals.</p>



<p>Furthermore, Village Farms International has promising short-term support. For example, the company released its first-quarter earnings report in May, revealing <a href="https://seekingalpha.com/pr/19716834-village-farms-international-reports-strong-q1-24-results?hasComeFromMpArticle=false&amp;source=section%253Amain_content%257Cbutton%253Abody_link%257Cfirst_level_url%253Anews">$77.88 million</a> in revenue, a 21% year-over-year increase. Village Farms&rsquo; key drivers were a 28% year-over-year increase in Canadian retail cannabis sales and enhanced regional market share.</p>



<p>Furthermore, Village Farms&rsquo; fresh produce segment has recovered from its loss by posting $100,000 in net income. I believe the segment&rsquo;s turnaround is a sign of things to come on a firm-wide level, which could add substance to VFF stock&rsquo;s price-to-sales ratio of <a href="https://finance.yahoo.com/quote/VFF/key-statistics/">0.4x</a>.</p>



<p>Village Farms International is a scalable company. Although inefficiencies remain, I&rsquo;m bullish about VFF stock&rsquo;s prospects as it seems like a telling growth story.</p>



<h2>Agrify Corporation (AGFY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/agfy-stock-1600-300x169.jpg" alt="bearded man tending kale crops in urban communal garden, AGFY Stock"><div>Source: Joshua Resnick / Shutterstock.com</div></div><p><strong>Agrify</strong> (NASDAQ:<strong><a href="https://investorplace.com/stock-quotes/agfy-stock-quote/" target="_blank">AGFY</a></strong>) is a hardware and software company that offers various products to the cannabis industry. The firm generates multiple revenue streams, from software-as-a-service to facility development assistance. Moreover, Agrify services the medicinal and hemp end markets, providing it with critical diversification attributes.</p>



<p>I mainly included AGFY stock in today&rsquo;s list as it is an event-driven opportunity. The company recently sealed a <a target="_blank" href="https://ir.agrify.com/news-releases/news-release-details/agrify-corporation-announces-500k-turnkey-extraction-equipment#:~:text=TROY%2C%20Mich.%20%2C%20June%2011,Lab%20Equipment%20Package%20with%20Grotech">$500,000</a> turnkey contract to provide extraction equipment to Grotech farms. I believe the event adds volume to Agrify&rsquo;s revenue mix, allowing it the latitude to focus on developing additional products. In addition, the contract adds substance to AGFY&rsquo;s price-to-sales ratio of <a target="_blank" href="https://finance.yahoo.com/quote/AGFY/key-statistics/">0.08x</a>, suggesting that absolute value is in play.</p>



<p>It must be outlined that Agrify has a few risks. Firstly, the NASDAQ issued a non-compliance <a href="https://mjbizdaily.com/cannabis-tech-firm-agrify-converts-debt-to-equity-to-pacify-nasdaq/#:~:text=Cannabis%20technology%20company%20Agrify%20Corp,with%20Nasdaq's%20stock%20listing%20rules.">warning earlier this year</a> when Agrify&rsquo;s equity value fell below $2.5 million. However, the firm executed a $13.8 million debt-to-equity conversion to settle the dispute. Furthermore, AGFY is a young company with a short trading history, meaning it has yet to prove its intrinsic worth.</p>



<p>Despite having certain reservations about Agrify, I remain bullish and believe the stock will reach great heights!</p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>



<p><em>On the date of publication, Steve Booyens did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a></em>.</p>
<div><p>Steve Booyens co-founded Pearl Gray Equity and Research in 2020 and has been responsible for cross-asset research and PR ever since. Before founding the firm, Steve spent time working in various finance roles in London and South Africa. He holds an MSc in Investment Banking from Queen Mary &ndash; University of London. Furthermore, Steve obtained his CFA Charter on April 26, 2024, and is working toward his Ph.D. in Finance. His articles are published on various reputable web pages such as Seeking Alpha, TipRanks, Yahoo Finance, and Benzinga. Steve&rsquo;s articles on InvestorPlace don&rsquo;t constitute financial advice. However, they form an interesting juxtaposition between mainstream opinion and objective theory, allowing readers to benefit from unbiased commentary. Readers can expect coverage on frequently traded stocks, REITs, fixed-income funds, CEFs, and ETFs.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/3-vertical-farming-stocks-growing-profits-indoors/">3 Vertical Farming Stocks Growing Profits Indoors</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Vertical Farming Stocks Growing Profits Indoors

urban-gro (UGRO) has provided an announcement. The Company has announced plans to restate its financial documents for the end of the year and inter...

urban-gro Announces Restatement of Financials, Warns Investors

urban-gro expects Q2 revenue of $17.5M

Anthony Vendetti, an analyst from Maxim Group, maintained the Buy rating on urban-gro (UGRO – Research Report). The associated price target was rai...

Buy Rating Maintained for urban-gro Amid Re-audit, Backed by Strong Backlog and Favorable Market Prospects

Urban-gro receives Nasdaq notification of non-compliance

urban-gro (UGRO) has issued an update. Urban-gro, Inc. has been notified by Nasdaq for non-compliance due to a delay in filing their quarterly fina...

Urban-gro Receives Nasdaq Notice, Addresses Financial Report Errors

Urban-Gro awarded construction contract to build new Fogo De Chão restaurant

urban-gro secures contract for architectural design services

urban-gro ( ($UGRO) ) has issued an update. urban-gro, Inc., an integrated services firm in the Controlled Environment Agriculture sector, has secu...

urban-gro Secures $12M in U.S. Cannabis Industry Contracts

urban-gro selected to provide full architectural and interior design services for HCWA project

AGFY

UGRO

Press Releases

urban-gro, Inc. Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance

urban-gro, Inc. Announces the Appointment of Sadler, Gibb & Associates LLC as Audit Firm

urban-gro Signs Approximately $12M in New Cannabis Sector Contracts in the Second Quarter

urban-gro, Inc. Announces Delayed 10-Q Filing and Restatement of Previously Issued Financial Statements Tied to Incorrect Accounting of Deferred Tax Liabilities Associated with Historical Acquisitions

Comments

Urban-gro

Vendite allo scoperto

Urban-gro (NASDAQ:UGRO) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO